British journal of anaesthesia
-
We have used Median Power Frequency (MPF) to study changes in the electroencephalogram during propofol infusions in 52 women about to undergo gynaecological surgery. Patients were allocated to receive propofol by one of nine different manually-controlled infusion schemes designed to achieve and maintain a stable blood propofol concentration between 1.0 and 6.0 micrograms ml-1, covering a range of states between conscious sedation and full anaesthesia. We recorded the changes in MPF and the response to clinical signs of loss of consciousness at these different doses and concentrations of propofol. ⋯ The EC50 for loss of consciousness was a propofol concentration of 2.3 (1.8-2.7) micrograms ml-1 and for 50% suppression of MPF was 3.1 (2.7-3.5) micrograms ml-1. The dose required for 50% suppression of MPF was 7.1 (6.2-8.0) mg kg-1 h-1. After 30 min, at blood propofol concentrations > 4.0 micrograms ml-1, consistent with stable anaesthesia, the mean MPF was 5.6 (4.5-6.3) Hz.
-
In this study we have measured arterial concentrations of isoflurane obtained during Caesarean section in two groups of patients. Patients in group 1 received 1% isoflurane throughout operation, whilst those in group 2 received 2% isoflurane for the first 5 min, 1.5% for the next 5 min and 0.8% thereafter. ⋯ Isoflurane concentrations greater than 30 micrograms ml-1 were achieved rapidly in most patients in both groups, but there was a large scatter of results. The isoflurane concentration at which awareness or recall may occur is not known, but an "overpressure" technique as described for patients in group 2 may result in fewer patients being at risk of awareness.
-
Flow-volume loops were monitored continuously in 39 patients undergoing thoracic surgery requiring one-lung ventilation. In 26 of the 39 patients (67%), auto-positive end-expiratory pressure (auto-PEEP) was seen on the flow-volume curves during both two-lung and one-lung ventilation. Eighty-seven percent of the patients whose trachea was intubated with a smaller size (35- and 37-French gauge) double-lumen tracheal tube exhibited auto-PEEP, compared with patients in whom the tube used was larger (39- or 41-French gauge: 54% and 50%, respectively). Before operation, mean airway resistance was significantly greater in patients who exhibited auto-PEEP during anaesthesia (2.4 cm H2O litre-1 s) than in patients without auto-PEEP (1.7 cm H2O litre-1 s).
-
We have defined the infusion dose requirements of propofol to suppress consciousness and response to a variety of graded non-noxious and noxious stimuli in 52 unpremedicated patients aged 16-40 yr and 32 patients aged 41-65 yr. They were allocated to receive one of five loading dose-infusion schemes designed to establish stable conditions covering the range from wakefulness, through sedation, to loss of consciousness and anaesthesia. ⋯ In both groups the dose-response curves for suppression of proprioception, finger counting and perception of light touch in conscious patients were shifted to the left of the curves for loss of consciousness and eyelash reflex. Dose-response curves for noxious stimuli were shifted to the right of those for loss of consciousness.
-
Although mixed venous oxygen saturation (SVO2) is related to the reciprocal of cardiac output (CO) if both arterial oxygen content and oxygen consumption remain constant, simultaneous alterations in the three variables may occur immediately after discontinuation of cardiopulmonary bypass (CPB). To examine if continuous monitoring of SVO2 using a fibreoptic pulmonary artery catheter would be useful for detecting alterations in CO immediately after discontinuation of CPB, we have examined the relationships between changes in SVO2, cardiac index (CI), oxygen consumption and haemoglobin concentration in 15 cardiac surgical patients. ⋯ However, changes in SVO2 did not correlate with either oxygen consumption or haemoglobin concentration. The current results suggest that continuous monitoring of SVO2 with the fibreoptic pulmonary artery catheter may be useful for detecting changes in CO after discontinuation of CPB in patients with compromised cardiac function.